Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer
Aging · 2023
DOI: 10.18632/aging.204564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Hongrun Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, China Aerospace Science and Industry Corporation 731 Hospital, Beijing 100074, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, China Aerospace Science and Industry Corporation 731 Hospital, Beijing 100074, China.
- Department of Social Work, The First People's Hospital of Fuyang District of Hangzhou, Hangzhou 311400, Zhejiang, China.
- Department of Urology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, China.
Zitieren
APA
Chen, H., Zhang, L., Zuo, M., Lou, X., Liu, B., & Fu, T. (2023). Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer. Aging. https://doi.org/10.18632/aging.204564
Vancouver
Chen H, Zhang L, Zuo M, Lou X, Liu B, Fu T. Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer. Aging. 2023. doi:10.18632/aging.204564
BibTeX
@article{Chen2023,
author = {Chen, Hongrun and Zhang, Lianfeng and Zuo, Meini and Lou, Xiaowen and Liu, Bin and Fu, Taozhu},
title = {Inhibition of apoptosis through AKT-mTOR pathway in ovarian cancer and renal cancer},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204564}
}
EUVIMED